PARTNER WITH US At Evaxion we welcome inquiries about new potential collaborations involving antigen discovery and lead development for new vaccine targets and interest in our current cancer and infectious disease programs.
At Evaxion, we partner at various stages
Target Discovery
At Evaxion, we leverage the unique predictive capabilities of our proprietary AI-Immunology™ platform to accelerate vaccine target discovery and selection for cancer and infectious diseases.
Clinical Responders
At Evaxion, we harness our proprietary clinical data and predictive capabilities to develop patient responder models
Partnership Inquiry
If you would like to partner with Evaxion and our AI-Immunology™ powered vaccine discovery platform or have a technology with the potential to become an immunological treatment for a disease with an unmet medical need, we look forward to hearing from you:
Subscribe to our Newsletter
Be the first to know about news, milestones and events at Evaxion by subscribing to our newsletter. You'll only hear from us when it's important, and can unsubscribe at any time.